Company intelligence / Profile preview

3Scan

San Francisco, California, United States

Ownership: Private
Employees: ~35
Development stage: Other

Overview

3Scan did not develop therapeutic drugs; it operated as a contract research and digital pathology platform providing automated 3D histology and quantitative tissue imaging services for preclinical research, not clinical trials.[1][2]

Industry: Pathology

Partnerships

Pharmaceutical companies (preclinical imaging and histopathology services)[1][2][3]Academic and translational medical research groups[1][2][3]Biotech and tissue engineering researchers[1][2]

Beyond the preview

Go deeper on 3Scan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3Scan.

Explore the full profile